rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1-2
|
pubmed:dateCreated |
2011-6-6
|
pubmed:abstractText |
We aimed to study the influences of active epilepsy and intellectual disability (ID) on the serum interleukin-6 (IL-6) by determining levels in 74 patients with developmental disorder with epilepsy and 63 healthy controls. The patients showed significantly higher IL-6 levels than the controls (4.1±4.5pg/ml vs. 2.1±1.0pg/ml; p<0.001). High seizure frequency and severe intellectual disability emerged as predictors for elevated serum levels of IL-6.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1872-6844
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright © 2011 Elsevier B.V. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
95
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
184-7
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:21530175-Adolescent,
pubmed-meshheading:21530175-Adult,
pubmed-meshheading:21530175-Anticonvulsants,
pubmed-meshheading:21530175-Autistic Disorder,
pubmed-meshheading:21530175-Down Syndrome,
pubmed-meshheading:21530175-Drug Therapy, Combination,
pubmed-meshheading:21530175-Epilepsy,
pubmed-meshheading:21530175-Female,
pubmed-meshheading:21530175-Hippocampus,
pubmed-meshheading:21530175-Humans,
pubmed-meshheading:21530175-Inflammation,
pubmed-meshheading:21530175-Intellectual Disability,
pubmed-meshheading:21530175-Interleukin-6,
pubmed-meshheading:21530175-Male,
pubmed-meshheading:21530175-Middle Aged,
pubmed-meshheading:21530175-Sclerosis,
pubmed-meshheading:21530175-Young Adult
|
pubmed:year |
2011
|
pubmed:articleTitle |
The serum level of interleukin-6 in patients with intellectual disability and refractory epilepsy.
|
pubmed:affiliation |
Department of Neurosurgery, Tampere University Hospital, Teiskontie 35, Tampere, Finland. kai.lehtimaki@pshp.fi
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|